Psilocybin
Psilocybin is a pharmaceutical drug with 167 clinical trials. Currently 76 active trials ongoing. Historical success rate of 94.8%.
Success Metrics
Based on 55 completed trials
Phase Distribution
Phase Distribution
72
Early Stage
79
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
79.7%
55 of 69 finished
20.3%
14 ended early
76
trials recruiting
167
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Effects of Psilocybin in Obsessive Compulsive Disorder
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Clinical Trials (167)
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Effects of Psilocybin in Obsessive Compulsive Disorder
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
A Randomized Neuroimaging Trial of Psilocybin in Depression
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
Psilocybin for Treatment-Resistant Depression in Autism
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Psilocybin-assisted Treatment for Cannabis Use Disorder
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Psilocybin-facilitated Treatment for Chronic Pain
Open-Label Psilocybin Study in Transdiagnostic Population
Exploratory Study of Low Dose Psilocybin
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 167